TNF-alpha/IL-1 ligand inhibitors (NanoSmart Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTNF-alpha/IL-1 ligand inhibitors (NanoSmart Pharmaceuticals)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionInterleukin-1 inhibitorsTumor necrosis factor α inhibitors
TargetsInterleukin-1Tumor necrosis factor α
Therapy Area/IndicationsArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNanosmart Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNanosmart Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsArthritis

Other Information

ATC CodeN/A
Related LinksN/A